SCHEMBL16809588

SCHEMBL16809588

C=Cc1ncnc2c1ccn2S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.49
POLB P06746 1/20 0.39
ALDH3A1 P30838 1/20 0.39
HTT P42858 1/20 0.39
NOD1 Q9Y239 1/20 0.39
RAPGEF4 Q8WZA2 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
KDM4E B2RXH2 1/20 0.38
UBE2N P61088 1/20 0.38
BRD4 O60885 1/20 0.37
PKM P14618 2/20 0.37
HTR6 P50406 2/20 0.36
GBA1 P04062 1/20 0.36
RAB9A P51151 1/20 0.36
TSHR P16473 2/20 0.35
MAPT P10636 1/20 0.35
CYP2C19 P33261 2/20 0.35
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16809866 0.87 CYP2C19 (0.48) L3MBTL1HTTPKMHTR6TSHR
SCHEMBL260617 0.82 L3MBTL1 (0.55) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL5268905 0.80 L3MBTL1 (0.43) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL30752005 0.80 L3MBTL1 (0.52) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL1356181 0.80 L3MBTL1 (0.52) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL28622254 0.80 L3MBTL1 (0.52) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL4075074 0.80 L3MBTL1 (0.52) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL14427677 0.80 L3MBTL1 (0.52) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL31409677 0.80 L3MBTL1 (0.46) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL15428434 0.79 L3MBTL1 (0.48) L3MBTL1POLBALDH3A1HTTNOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015089327-A1 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY BIOGEN IDEC MA INC. (US) 2015-06-18 WO disclosed